HDAC9 and breast carcinoma: Our findings suggest a mechanism through which calcium influx is modulated by epigenetic remodeling, wherein the HDAC inhibitor PCI-24781 can alter calcium signaling, thereby affecting apoptosis, cell proliferation, and cell differentiation to inhibit breast cancer progression (Figure 7I).